Related Experiment Videos
Initiation of blood coagulation: the tissue factor/factor VIIa complex
1Pharma Division, F Hoffmann-La Roche, Basel, Switzerland. daniel.kirchhofer@roche.com
Current Opinion in Biotechnology
|August 1, 1996
Summary
Tissue factor (TF) initiates blood coagulation and is implicated in diseases like sepsis. New research suggests TF may also function as an intracellular signaling receptor in monocytes.
Area of Science:
- Biochemistry
- Immunology
- Cell Biology
Background:
- Tissue factor (TF) is a transmembrane glycoprotein crucial for initiating blood coagulation via the factor VIIa complex.
- The TF/VIIa complex plays a role in pathophysiological processes including Gram-negative sepsis, coronary artery disease, and neointimal hyperplasia.
- Monocytes/macrophages are key cellular players in these TF-mediated diseases, with emerging insights into TF regulation within these cells.
Purpose of the Study:
- To explore the emerging evidence for Tissue Factor's role beyond coagulation.
- To investigate the potential intracellular signaling functions of Tissue Factor, particularly in monocytes.
- To understand the implications of TF's proposed receptor function in disease pathogenesis.
Main Methods:
- Review of recent studies on TF biology and function.
- Analysis of TF's structural similarities to cytokine receptors.
- Examination of evidence supporting TF's role in intracellular signaling pathways.
Main Results:
- Recent studies support the hypothesis that Tissue Factor may act as a true receptor.
- Evidence suggests TF's involvement in intracellular signaling pathways, particularly in monocytes/macrophages.
- TF's dual role in coagulation initiation and potential signaling impacts understanding of related diseases.
Conclusions:
- Tissue Factor's function extends beyond initiating coagulation, with evidence supporting a role in intracellular signaling.
- The proposed receptor function of TF in monocytes/macrophages opens new avenues for understanding and treating TF-associated diseases.
- Further research is warranted to fully elucidate the signaling mechanisms and therapeutic potential of TF.